Corporate Tech Investors

Adimab

Adimab is a corporate VC investing group that invests in companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Adimab's yeast-based discovery platform functions as a synthetic human immune system to create novel antibody therapeutics across an extensive range of diseases, including cancer as well as autoimmune and infectious diseases. We are a profitable privately-held biotech company, backed by top-tier venture capital firms including Google Ventures, OrbiMed Advisors, Polaris Partners, and SV Life Sciences. We are unique in our ability to take a long-term view on value creation which allows us to continuously refine and improve our technology and make substantial investments in R&D.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/20/2021

Transaction History

Our records indicate that Adimab invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Tillman Gerngross

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Adimab has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Adidas | Adisseo

Share this article

About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a market leader in strategic investor transaction data for corporations that invest in the tech sector.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary